INHIBITORS OF INDUCIBLE FORM OF 6-PHOSPHOFRUCTOSE-2-KINASE

The invention is directed to inhibitors of inducible form of 6-phosphofructose-2-kinase of formula I, as well as to pharmaceutically acceptable salts of formula I, and pharmaceutical compositions comprising a compound of formula I. The compounds can be used to treat cancer. La présente invention con...

Full description

Saved in:
Bibliographic Details
Main Authors MOON, KIM, KEARNEY, PATRICK, TSUHAKO, AMY, LEW, ZAHARIA, CHRISTIANA, A, BAJJALIEH, WILLIAM, TESFAI, ZEROM, AAY, NAING, MARLOWE, CHARLES, K, HUANG, PING, XU, WEI, KABIGTING, LORI, NUSS, JOHN, M, TAMBO-ONG, ARLYN
Format Patent
LanguageEnglish
French
Published 01.11.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The invention is directed to inhibitors of inducible form of 6-phosphofructose-2-kinase of formula I, as well as to pharmaceutically acceptable salts of formula I, and pharmaceutical compositions comprising a compound of formula I. The compounds can be used to treat cancer. La présente invention concerne des inhibiteurs de la forme inductible de la 6-phosphofructose-2-kinase de formule (I), ainsi que les sels pharmaceutiquement acceptables de formule (I), et des compositions pharmaceutiques comprenant un composé de formule (I). Les composés peuvent servir à traiter le cancer.
AbstractList The invention is directed to inhibitors of inducible form of 6-phosphofructose-2-kinase of formula I, as well as to pharmaceutically acceptable salts of formula I, and pharmaceutical compositions comprising a compound of formula I. The compounds can be used to treat cancer. La présente invention concerne des inhibiteurs de la forme inductible de la 6-phosphofructose-2-kinase de formule (I), ainsi que les sels pharmaceutiquement acceptables de formule (I), et des compositions pharmaceutiques comprenant un composé de formule (I). Les composés peuvent servir à traiter le cancer.
Author TAMBO-ONG, ARLYN
ZAHARIA, CHRISTIANA, A
KABIGTING, LORI
XU, WEI
BAJJALIEH, WILLIAM
AAY, NAING
MOON, KIM
NUSS, JOHN, M
KEARNEY, PATRICK
TESFAI, ZEROM
HUANG, PING
MARLOWE, CHARLES, K
TSUHAKO, AMY, LEW
Author_xml – fullname: MOON, KIM
– fullname: KEARNEY, PATRICK
– fullname: TSUHAKO, AMY, LEW
– fullname: ZAHARIA, CHRISTIANA, A
– fullname: BAJJALIEH, WILLIAM
– fullname: TESFAI, ZEROM
– fullname: AAY, NAING
– fullname: MARLOWE, CHARLES, K
– fullname: HUANG, PING
– fullname: XU, WEI
– fullname: KABIGTING, LORI
– fullname: NUSS, JOHN, M
– fullname: TAMBO-ONG, ARLYN
BookMark eNrjYmDJy89L5WSw8vTz8HTyDPEPClbwd1Pw9HMJdfZ08nFVcPMP8gWJmOkGePgHA7FbUKhziH-wq66Rrrenn2OwKw8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstiQ_3NzIwNDI0sTQ1snA0NCZOFQBZASuR
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE LA FORME INDUCTIBLE DE LA 6-PHOSPHOFRUCTOSE-2-KINASE
ExternalDocumentID WO2012149528A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2012149528A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:58 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2012149528A13
Notes Application Number: WO2012US35794
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121101&DB=EPODOC&CC=WO&NR=2012149528A1
ParticipantIDs epo_espacenet_WO2012149528A1
PublicationCentury 2000
PublicationDate 20121101
PublicationDateYYYYMMDD 2012-11-01
PublicationDate_xml – month: 11
  year: 2012
  text: 20121101
  day: 01
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies TAMBO-ONG, ARLYN
ZAHARIA, CHRISTIANA, A
KABIGTING, LORI
XU, WEI
BAJJALIEH, WILLIAM
AAY, NAING
MOON, KIM
NUSS, JOHN, M
EXELIXIS, INC
KEARNEY, PATRICK
TESFAI, ZEROM
HUANG, PING
MARLOWE, CHARLES, K
TSUHAKO, AMY, LEW
RelatedCompanies_xml – name: EXELIXIS, INC
– name: KEARNEY, PATRICK
– name: KABIGTING, LORI
– name: HUANG, PING
– name: AAY, NAING
– name: ZAHARIA, CHRISTIANA, A
– name: NUSS, JOHN, M
– name: XU, WEI
– name: TESFAI, ZEROM
– name: TSUHAKO, AMY, LEW
– name: BAJJALIEH, WILLIAM
– name: MARLOWE, CHARLES, K
– name: MOON, KIM
– name: TAMBO-ONG, ARLYN
Score 2.863967
Snippet The invention is directed to inhibitors of inducible form of 6-phosphofructose-2-kinase of formula I, as well as to pharmaceutically acceptable salts of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title INHIBITORS OF INDUCIBLE FORM OF 6-PHOSPHOFRUCTOSE-2-KINASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121101&DB=EPODOC&locale=&CC=WO&NR=2012149528A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1bS8MwFIAPY4r6plPxMqWg9C24Xm2FIWva0optSi-6t7HeQJBuuIp_39Ou0z3tIZALHE4CJ8mX5JwA3OdpnpdSOSeCqmZEVrSU6KlSkALBTROUVBZGjTey56tOIr9MlWkPPje-MG2c0J82OCJaVIb2Xrfz9fL_EMts31auHtIPrFo82_HY5Ds6buKVIRubxtgKmMkoTylyG--H6zaEAVGbICvt4Ub6sXkAZr0ZjV_KcntRsY9hP0B5VX0CvaIawCHd_L02gAOvu_LGbGd9q1N4cn3HNdyYhRHHbM71zYS6xqvFIcl5TY1KAodFmOwwoTGLLCISxPNJZJ3BnW3F1CGoxOyvz7N3tq2xdA79alEVF8BJUqbnuSQKZaEiG2m439AlGWepeZ6N5nJ5CcNdkq52N1_DUVNcO9sNoV9_fRc3uOrW6W07WL_B8oBZ
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3dS8MwEMCPMcX5plNxOrWg9C24ftIJQ9a0pdW1KWunexv9BEG64Sr--167Tve0h0DIwZEELrlfkrsAPKRxmuZSHhFBVRMiK1pMhrGSkQzBTROUWBYGVTSy66n2TH6ZK_MWfG5jYeo8oT91ckS0qATtvazX69X_IZZRv61cP8Yf2LR8tsKRwTd0XOUrQzY29JHpM4NRnlLkNt6bbmQIA6I2RlY6QCdbqzLtm296FZey2t1UrBM49FFfUZ5CKyu60KHbv9e6cOQ2V95YbaxvfQZPjmc7uhOyacAxi3M8Y0YdfWJySHJu1aIS32YBFms6oyELTCISxPNxYJ7DvWWG1CbYicXfmBfvbLfH0gW0i2WRXQInSckwTSVRyDMV2UhDf2MoybhKRWkyiOS8B_19mq72i--gY4fuZDFxvNdrOK5Em8C7PrTLr-_sBnfgMr6tJ-4X7zyDSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+INDUCIBLE+FORM+OF+6-PHOSPHOFRUCTOSE-2-KINASE&rft.inventor=MOON%2C+KIM&rft.inventor=KEARNEY%2C+PATRICK&rft.inventor=TSUHAKO%2C+AMY%2C+LEW&rft.inventor=ZAHARIA%2C+CHRISTIANA%2C+A&rft.inventor=BAJJALIEH%2C+WILLIAM&rft.inventor=TESFAI%2C+ZEROM&rft.inventor=AAY%2C+NAING&rft.inventor=MARLOWE%2C+CHARLES%2C+K&rft.inventor=HUANG%2C+PING&rft.inventor=XU%2C+WEI&rft.inventor=KABIGTING%2C+LORI&rft.inventor=NUSS%2C+JOHN%2C+M&rft.inventor=TAMBO-ONG%2C+ARLYN&rft.date=2012-11-01&rft.externalDBID=A1&rft.externalDocID=WO2012149528A1